Quince Therapeutics, Inc. (QNCX)
1.145
-0.04
(-2.97%)
USD |
NASDAQ |
May 15, 12:37
Quince Therapeutics Total Liabilities (Quarterly) : 10.95M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 314.75M |
| BioXcel Therapeutics, Inc. | 142.98M |
| Gossamer Bio, Inc. | 295.01M |
| Ernexa Therapeutics, Inc. | 3.684M |
| Acurx Pharmaceuticals, Inc. | 2.527M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.62M |
| Shareholders Equity (Quarterly) | 15.67M |
| Debt to Equity Ratio | 0.0259 |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | 50.99% |